Industry – Page 2

Drugmakers renew concerns over UK’s attractiveness for investment

1 month ago talkbio0Tagged attractiveness, concerns, Industry, Investments, UK, UK 's

Investments, UK, UK ‘s, concerns, Industry, attractiveness

Lonza’s Vision for the Future: A Fireside Chat with New CEO Wolfgang Wienand

1 month ago talkbio0Tagged Biological Factors, CDMO, Cells, gene therapy, Industry, Leadership, Lonza, pharmaceutical manufacturing, Small Molecule, Wolfgang Wienand

Lonza, Wolfgang Wienand, CDMO, Pharmaceutical manufacturing, Biologics, Cell and gene therapy, Small molecules, Leadership transition, Industry outlook

Sofinnova Partners Secures €1.2 Billion for Life Sciences Innovation

2 months ago talkbio0Tagged Capital, digital medicine, Health care facility, Industry, medtech, sustainability, venture

Venture capital, biotech, medtech, digital medicine, industrial biotech, healthcare, sustainability

FDA Moves to Rehire Some Recently Fired Employees Amid Backlash

2 months ago talkbio0Tagged Administration occupational activities, Industry, Medical Devices, public health agencies, Transplant Registry Unified Management Program, Trump, United States Food and Drug Administration

FDA, layoffs, rehiring, Trump administration, medical device industry, public health agencies

Bluebird Bio’s Fall from Grace: Gene Therapy Pioneer Sells for $29M After $10B Valuation

2 months ago talkbio0Tagged Acquisition, Capital, Carlyle, DKK1 gene, Family Turdidae (organism), Financial Stress, gene therapy, Industry, Private Equity

Bluebird Bio, gene therapy, private equity, Carlyle, SK Capital, financial challenges, acquisition, biotech industry

Trump’s Healthcare Nominees Pledge to Divest Industry Investments Amid Controversy

2 months ago talkbio0Tagged Bhattacharya, healthcare appointments, Industry, Jay, Jr., Mehmet, Myasthenic Syndromes, Congenital, NIH, NIH Mouse, ounce, ties, Transplant Registry Unified Management Program

Trump administration, healthcare appointments, NIH, CMS, divestment, industry ties, Jay Bhattacharya, Mehmet Oz, Robert F. Kennedy Jr.

Illumina’s Double-Edged Sword: Navigating US-China Trade Tensions

3 months ago talkbio0Tagged BIOSECURE, China, DNA Sequence, Entity, Illumina, Industry, Tension, TNFRSF19 gene, unreliable

Illumina, China, tariffs, trade tensions, DNA sequencing, unreliable entity list, biotech industry, BIOSECURE Act

Turnstone Biologics Discontinues Final Clinical Program, Initiates Strategic Review Amid Financial Constraints

3 months ago talkbio0Tagged Arenaria, Biological Factors, clinical program, Discontinuation (procedure), Financial cost, Industry, Lymphocytes, Tumor-Infiltrating, Manufacturing, strategic alternatives, TIDAL-01

Turnstone Biologics, TIDAL-01, clinical program discontinuation, layoffs, strategic alternatives, TIL therapy, manufacturing costs, biotech industry challenges